Active Ingredient(s): Bremelanotide Acetate
FDA Approved: * June 21, 2019
Pharm Company: * AMAG PHARMS INC
Category: Women's Health / Fertility

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Vyleesi Overview

Bremelanotide, sold under the brand name Vyleesi, is a medication used to treat low sexual desire in women.[2] Specifically it is used for low sexual desire which occurs before menopause and is not due to medical problems, psychiatric problems, or problems within the relationship.[3][4][2] It is given by an injection just under the skin of the thigh or abdomen.[2][4] Common side effects include nau...

Read more Vyleesi Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bremelanotide

Recent Vyleesi Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Bremelanotide Acetate
  • Solution: 1.75mg/0.3ml (1.75mg/0.3 Ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Vyleesi: (1 result)

Sorted by National Drug Code
  • 64011-701 Vyleesi 1.75 mg/.3ml Subcutaneous Injection by Amag Pharmaceuticals, Inc.

Other drugs which contain Bremelanotide Acetate or a similar ingredient: (1 result)